FERRARO, Diana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.537
AS - Asia 5.555
EU - Europa 5.221
SA - Sud America 1.008
Continente sconosciuto - Info sul continente non disponibili 210
AF - Africa 145
OC - Oceania 51
Totale 28.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.190
GB - Regno Unito 1.739
SG - Singapore 1.634
CN - Cina 1.269
IT - Italia 911
VN - Vietnam 778
BR - Brasile 747
HK - Hong Kong 732
DE - Germania 483
SE - Svezia 410
FI - Finlandia 389
BD - Bangladesh 307
FR - Francia 246
RU - Federazione Russa 242
UA - Ucraina 200
CA - Canada 181
TR - Turchia 133
BG - Bulgaria 129
IN - India 118
KR - Corea 112
AR - Argentina 95
ID - Indonesia 95
MX - Messico 76
ES - Italia 66
NL - Olanda 57
CZ - Repubblica Ceca 51
AU - Australia 50
PL - Polonia 50
IQ - Iraq 49
JP - Giappone 48
AT - Austria 43
ZA - Sudafrica 42
EC - Ecuador 41
AE - Emirati Arabi Uniti 35
IE - Irlanda 34
CL - Cile 31
MY - Malesia 29
PK - Pakistan 29
IR - Iran 27
CH - Svizzera 26
BE - Belgio 25
CO - Colombia 25
DK - Danimarca 25
VE - Venezuela 24
MA - Marocco 20
PH - Filippine 20
EG - Egitto 19
JO - Giordania 17
PY - Paraguay 17
KE - Kenya 16
LT - Lituania 16
TN - Tunisia 16
CR - Costa Rica 15
JM - Giamaica 13
BZ - Belize 12
TW - Taiwan 12
UY - Uruguay 12
PE - Perù 11
SA - Arabia Saudita 11
GE - Georgia 10
PT - Portogallo 10
UZ - Uzbekistan 10
NP - Nepal 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
RO - Romania 8
HN - Honduras 7
IL - Israele 7
DZ - Algeria 6
EE - Estonia 6
GR - Grecia 6
GT - Guatemala 6
HU - Ungheria 6
OM - Oman 6
QA - Qatar 6
TH - Thailandia 6
AL - Albania 5
BB - Barbados 5
KZ - Kazakistan 5
LB - Libano 5
NO - Norvegia 5
RS - Serbia 5
SI - Slovenia 5
BO - Bolivia 4
PA - Panama 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
ET - Etiopia 3
GA - Gabon 3
HR - Croazia 3
KW - Kuwait 3
LK - Sri Lanka 3
MD - Moldavia 3
NG - Nigeria 3
SV - El Salvador 3
Totale 28.468
Salva come PNG Salva come JPEG
Città #
Fairfield 1.819
Ashburn 1.709
Santa Clara 1.415
Southend 1.203
Singapore 959
Woodbridge 872
Seattle 722
Hong Kong 720
Houston 713
San Jose 639
Chandler 625
Cambridge 605
Wilmington 554
Council Bluffs 391
Ann Arbor 354
Helsinki 326
Dearborn 317
Chicago 306
London 301
Jacksonville 292
Nyköping 284
Ho Chi Minh City 254
Los Angeles 249
New York 235
Beijing 227
Hanoi 183
Modena 177
Hefei 165
The Dalles 156
San Diego 143
Munich 135
Sofia 122
Princeton 120
Salt Lake City 110
Shanghai 88
Buffalo 86
Moscow 86
Dallas 84
Milan 83
Seoul 81
Lauterbourg 78
Columbus 73
Eugene 73
São Paulo 67
Jakarta 66
Toronto 58
Frankfurt am Main 55
Tampa 53
Elk Grove Village 50
Phoenix 49
Bremen 47
North Bergen 47
Rome 46
Orem 45
Izmir 44
Redwood City 42
Miami 40
Norwalk 39
Da Nang 38
Carrboro 37
Warsaw 35
Boardman 34
Rio de Janeiro 32
Boston 30
Málaga 30
Redondo Beach 30
Washington 30
Brno 29
Manchester 29
Tokyo 29
Dublin 28
Guangzhou 28
Sterling 28
Turku 28
Vienna 27
Fremont 26
Haiphong 26
Lancaster 26
Amsterdam 25
Melbourne 24
Atlanta 23
Chennai 23
Montreal 23
Seongnam 23
Stockholm 23
Brooklyn 22
Dulles 22
Hillsboro 22
Johannesburg 22
Kunming 22
Baghdad 21
Naples 21
Paris 21
Mexico City 20
Miano 20
Nuremberg 20
San Francisco 20
Bar Harbor 18
Bologna 18
Buenos Aires 18
Totale 19.953
Salva come PNG Salva come JPEG
Nome #
Definitive childlessness in women with multiple sclerosis: a multicenter study 690
Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis 476
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome. 462
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study 460
A quantitative comparison of BOLD fMRI responses to noxious and innocuous stimuli in the human spinal cord 422
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV 411
Isolated progressive cognitive impairment and depression in a patient with neuroradiological features suggestive of multiple sclerosis 404
Invariant natural killer T cells and mucosal-associated invariant T cells in multiple sclerosis 404
Recurrent varicella following steroids and fingolimod in a Multiple Sclerosis patient 398
Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study 393
iNKT cells in secondary progressive multiple sclerosis patients display pro-inflammatory profiles 385
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 381
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: Results from an observational study 378
False positive absent somatosensory evoked potentials in cardiac arrest with therapeutic hypothermia. 374
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence 367
Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study 357
Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study 352
Acute hemichorea as unusual first multiple sclerosis presentation 351
Paroxysmal ventricular tachicardia and pure right insular stroke 345
Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome 343
Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients 343
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 342
Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia 340
Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis 328
Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study 326
Methylprednisolone-induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses 318
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study 318
Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band‐negative patients with suspected multiple sclerosis 311
Inter-center agreement in the interpretation of oligoclonal bands 303
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM 297
Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients 297
Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis 295
Semiautomated segmentation of the human spine based on echoplanar images 292
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 289
Antiepileptic drugs in the treatment of headache: Neuroprotective effect or something else? 288
Severe anemia in a patient with multiple sclerosis treated with natalizumab 282
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 276
Diagnostics of dysimmune peripheral neuropathies 274
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 274
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS 273
Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine 272
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect? 272
Acute necrotizing encephalopathy: A relapsing case in a European adult [4] 271
Diagnostics of anti-MAG antibody polyneuropathy 268
Topiramate in migraine prophylaxis: A randomised double-blind versus placebo study 264
Abnormal Circadian Modification of Aδ-Fiber Pathway Excitability in Idiopathic Restless Legs Syndrome 264
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 260
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis 260
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis 259
Antiepileptic drugs in the preventive treatment of migraine in children and adolescents 252
The abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate 251
Charcot-Marie-Tooth and pain: Correlations with neurophysiological, clinical, and disability findings 250
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 250
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 248
Habituation to Pain in "Medication Overuse Headache": A CO2 Laser-Evoked Potential Study 247
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study) 246
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis 244
Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: A laser-evoked potential study 243
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study 240
Detection of Neurofilament Light Chain with Label-Free Electrolyte-Gated Organic Field-Effect Transistors 236
Acute hemichorea as unusual first multiple sclerosis presentation: two case reports 231
Topiramate in the prevention of pediatric migraine: Literature review 228
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 228
Left thalamomegaly in a patient with partial epilepsy 228
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: Acetylcholinesterase activity cannot be considered a useful biomarker 227
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients 226
Letter to Editor: Carpal tunnel syndrome due to an atypical deep soft tissue leiomyoma: The risk of misdiagnosis and mismanagement 224
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study 224
Multiple attack study on the available triptans in Italy versus placebo 223
Cell-based assays for the detection of MOG antibodies: a comparative study 219
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy 217
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis 214
Evidence of different spinal pathways for the warmth evoked potentials 213
A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis 212
Kappa Index Versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders 211
Treatment response score to glatiramer acetate or interferon beta-1a 205
Informing MS patients on treatment options: a consensus on the process of consent taking 203
Antiepileptic drugs in migraine prophylaxis: state of the art 201
Microglia activation: A role for mitochondrial DNA? 199
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 198
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing–remitting multiple sclerosis 197
Occupational head injury and subsequent glioma 195
Risk of secondary progressive multiple sclerosis: A longitudinal study 191
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 191
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis 190
Modulation of tregs and inkt by fingolimod in multiple sclerosis patients 189
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients 184
Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years 184
Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus 182
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 178
A novel SOD1 mutation in a young ALS patient associated with slowly progressive clinical course 170
Association of Sustained Immunotherapy with Disability Outcomes in Patients with Active Secondary Progressive Multiple Sclerosis 163
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 162
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder 158
A study of the CD45 exon 4 C77G polymorphism in a patient affected both by multiple sclerosis and pulmonary Langerhans' cell histiocytosis 149
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 149
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 148
The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies 144
Early clinical markers of aggressive multiple sclerosis 143
Exploring the Role of Diabetes in ALS: A Population-Based Cohort Study 138
Totale 27.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.631 0 0 0 93 40 134 107 141 252 225 403 236
2022/20231.749 198 206 146 181 198 250 21 191 193 13 102 50
2023/20241.247 33 77 60 158 229 108 147 155 30 15 63 172
2024/20254.290 151 37 47 322 911 713 198 213 499 242 382 575
2025/20268.873 525 336 704 1.013 1.399 673 967 476 842 727 681 530
2026/20271.894 383 526 618 367 0 0 0 0 0 0 0 0
Totale 28.727